← Back to all trials
Completed
NCT05627102
Percutaneous Electrolysis, Ultrasound-Guided Percutaneous Neuromodulation Therapy and Eccentric Exercise in Supraspinatus Tendinopathy
Conditions: Supraspinatus Tendinitis
Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 50
Sponsor: University of Cadiz
Location: Spain
Summary
The supraspinatus muscle tendinopathy show a big impact, however, there is a lack of awareness about the options of the physiotherapist treatment.
It is necessary to do studies about effectiveness of therapeutic percutaneous electrolysis and neuromodulation.
This technique enables treatment of the tendinopathies.
To analyze the effectiveness of therapeutic percutaneou electrolysis and neuromodulation in the treatment of supraspinatus muscle tendinopathy.
Single center randomized controlled trial, parallel treatment design.
A specialist physician will be diagnosed the supraspinatus muscle tendinopathy.
Participants will be randomly assigned to receive treatmen for 4 weeks: percutaneou electrolysis and neuromodulation associated with eccentric exercises or conventional treatment of Physiotherapy with the same eccentric exercises.
Both interventions were performed under ultrasound guidance with a portable ultrasound (General Electric LogicE).
Data will be collected by a blinded evaluator.
Eligibility Criteria
Inclusion Criteria:Patients diagnosed with supraspinatus tendinopathies that do not improve with conventional physiotherapy or pharmacological therapy protocols.Subjects who are in an active state of pain, who present painful symptoms in a sensitive and painful area of the tendon of insertion of the supraspinatus muscle in the humerus.Exclusion Criteria:Individuals who have received surgery intervention in the same shoulder, or have suffered fractures or dislocations in the same shoulder.Individuals have received the proposed treatment in one month´s period previously.Individuals who suffering from cervical radiculopathies, fibromialgia síndrome, cardiac patients with pacemakers, cancer, infectious processes, or generalized lymphedema.Pregnant women can not receive this treatment intervention.
Source: ClinicalTrials.gov (NCT05627102). StuddyBuddy aggregates publicly available trial information.